PER 34.1% 8.9¢ percheron therapeutics limited

Ann: Antisense Therapeutics appoints new Non-Executive Director, page-38

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,588 Posts.
    lightbulb Created with Sketch. 1453
    Roche and Ionis abandon Stage 3 Huntington driug ... Maybe it could work in conjunction with Atl1102..?
    https://hotcopper.com.au/data/attachments/3030/3030523-d4f52f24a62832bc5e124c72da75ff17.jpg
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.